[조사자료] 글로벌 요로 감염증 검사 시장 (2023-2030) : 요도염, 방광염, 신우신염

■ 영문 제목 : Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End-use (Reference Laboratories, General Practitioners, Urologists), By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV185 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 115 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 임상 진단

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 요로 감염증 검사 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 요로 감염증 검사 시장은 2030년까지 8억 1201만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 4. 4%의 성장률을 기록할 것으로 전망됩니다. 요로 감염증 검사 시장은 질병 부담 증가, 노인 인구 증가, 급속한 기술 발전, 자가 검사 및 빠른 치료 시점(PoC) 기기 제품과 같은 새롭고 혁신적인 제품을 도입하기 위한 주요 기업의 높은 R&D 투자 등의 요인으로 인해 성장을 목격하고 있습니다.

요로 감염은 전 세계적으로 공통적인 관심사가 되고 있습니다. 연구에 따르면, 성인 여성 5명 중 1명이 일생 중 한 번은 요로감염을 경험하는 것으로 나타났습니다. 미국에서는 20~40세 여성의 약 25~40%가 요로결석증을 앓고 있습니다. 미국에서는 매년 약 25만 건의 신우신염이 보고되고 있으며, 18~19세 여성의 경우 발병률은 약 28/10,000이며, 이 중 7%는 입원이 필요합니다. 유전적, 문화적 요인이 유병률에 영향을 미칠 수 있으며, 예를 들어 한국의 신우신염 발생률은 약 59/10,000명당 1명꼴로 발생합니다. 재발률은 남성 5. 7%, 여성 9%로 다른 요로결석보다 더 흔합니다.

당뇨병 환자는 급성 방광염과 같은 요로 감염이 발생할 위험이 높기 때문에 전 세계 당뇨병 유병률 증가가 방광염의 증가에 기여한 것으로 추정되며, NCBI의 논문에 따르면 제2형 당뇨병은 요로 결석 위험을 증가시키고 제2형 당뇨병 환자는 빈번하고 심각한 요로 결석을 경험합니다. 국제당뇨병연맹(IDF) 자료에 따르면 2030년까지 약 6억 4,300만 명, 2045년까지 약 7억 8,300만 명이 당뇨병에 걸릴 것으로 예상됩니다. 또한, 당뇨병 여성의 무증상 세균뇨 유병률은 26%인 반면, 비당뇨병 여성의 무증상 세균뇨 유병률은 6%로 추정됩니다. 이러한 요인으로 인해 전 세계적으로 방광염의 유병률이 높아질 것으로 예상됩니다.

하지만 최근 들어 이러한 질환에 대한 인식이 높아지면서 전문 의료진의 치료 수요가 증가하고 있습니다. 미국 보건복지부에 따르면, 2020년 미국 내 개업 비뇨기과 전문의 수는 인구 10만 명당 4.07명이었습니다. 보고서는 또한 수요 증가로 인해 비뇨기과 의사가 부족해 2025년까지 3,600명 가까이 부족할 수 있다고 밝혔습니다. 이는 향후 몇 년 동안 시장 성장을 저해할 수 있습니다. 또한 코로나19는 업계에 부정적인 영향을 미치고 있습니다. 요로결석 환자들은 검사 및 응급의료에 큰 어려움을 겪고 있습니다.

주요 기업들은 포트폴리오를 강화하기 위해 새로운 제품을 출시하고 있습니다. 예를 들어, 2021년 9월, OpGen, Inc. 는 Univero Urinary Tract Infection Panel의 임상 시험 시작을 발표했습니다. 이 패널은 소변 샘플에서 직접 광범위한 병원체 및 항균제 내성 마커를 분석할 수 있습니다. 임상 시험의 성공과 이러한 기술적으로 진보되고 효율적인 제품의 출시는 향후 몇 년 동안 시장 성장을 촉진할 것으로 예상됩니다. 마찬가지로 2020년 7월 비뇨기 건강 생명 공학 기업 Uqora(Pharmavite, LLC)는 요로결석 진단 및 관리 키트를 출시했습니다. 이 키트에는 PoC 및 재택의료용 신속 요로결석 진단 장치인 클라리파이(Clarify)가 포함되어 있습니다.

요로 감염증 검사 시장 하이라이트

- 2022년 추정 시장 점유율은 41. 42%로 방광염이 시장을 주도했습니다. 그 배경에는 방광염의 높은 이환율과 재발률, 제품 승인 수 증가, 방광염에 걸리기 쉬운 당뇨병 환자가 많기 때문입니다.

- 기준 검사실 부문은 2022년 26. 66%의 점유율을 차지했는데, 이는 기준 검사실이 소매 수준에서 진단 시설을 제공함으로써 환자 결과를 개선하기 위한 노력을 계속하고 있기 때문입니다.

- 전체 요로감염증 시장에서는 북미가 금액 기준으로 우위를 점하고 있습니다. 이는 더 나은 상환 시설과 인지도가 높아짐에 따라 새로운 진단 제품의 채택이 증가했기 때문입니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변동, 동향, 범위
Chapter 4. 세계의 요로 감염증 검사 시장 : 최종 용도별 예측 및 동향 분석
Chapter 5. 세계의 요로 감염증 검사 시장 : 유형별 예측 및 동향 분석
Chapter 6. 세계의 요로 감염증 검사 시장 : 지역별 예측 및 동향 분석
Chapter 7. 경쟁 분석

■ 보고서 목차

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type segment
1.1.1.2. End-use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2 Executive Summary
2.1. Market Snapshot
2.2. Type and End-use Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3 Urinary Tract Infection Market Variables, Trends, and Scope
3.1 Parent Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Industry Analysis – Porter’s
3.3.1 Threat Of New Entrants: Moderate
3.3.2 Bargaining Power Of Buyers: Moderate
3.3.3 Competitive Rivalry: High
3.3.4 Threat Of Substitutes: Low
3.3.5 Bargaining Power Of Suppliers: Moderate
3.4 PESTEL Analysis (Political & Legal, Economic, and Technological)
3.4.1 Political & Legal
3.4.2 Economic
3.4.3 Technological
3.5 Consumer Behavior Analysis
3.5.1 Complex Buying
3.5.2 Habitual Buying Behavior
3.5.3 Reducing Buying Behavior
3.5.4 Variety Seeking
3.6 Market Driver Analysis
3.6.1 Technological Advancements and Increasing Adoption of Home-Based Testing
3.6.2 Rising Target Disease Incidence, and Growing Geriatric Population
3.7 Market Restraint Analysis
3.7.1 Rapid Testing Sensitivity & Accuracy And Availability of Refurbished Urine Analyser
3.8 Urine Culture Tests Performed in the U.S. and Canada
Chapter 4 Urinary Tract Infection Market: Segment Analysis, by End Use, 2018 – 2030 (USD Million) (Volume, Units)
4.1 Urinary Tract Infection Market: End-use Movement Analysis
4.2 General Practitioners
4.2.1 General Practitioners Market, 2018 – 2030 (USD Million)
4.2.2 General Practitioners Market, Instruments, 2018 – 2030 (USD Million)
4.2.3 General Practitioners Market, Instruments, 2018 – 2030, Volume (Units)
4.2.4 General Practitioners Market, Consumables, 2018 – 2030 (USD Million)
4.2.5 General Practitioners Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.3 Urologists
4.3.1 Urologists Market, 2018 – 2030 (USD Million)
4.3.2 Urologists Market, Instruments, 2018 – 2030 (USD Million)
4.3.3 Urologists Market, Instruments, 2018 – 2030, Volume (Units)
4.3.4 Urologists Market, Consumables, 2018 – 2030 (USD Million)
4.3.5 Urologists Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.4 Urogynecologists
4.4.1 Urogynecologists Market, 2018 – 2030 (USD Million)
4.4.2 Urogynecologists Market, Instruments, 2018 – 2030 (USD Million)
4.4.3 Urogynecologists Market, Instruments, 2018 – 2030, Volume (Units)
4.4.4 Urogynecologists Market, Consumables, 2018 – 2030 (USD Million)
4.4.5 Urogynecologists Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.5 Reference Laboratories
4.5.1 Reference Laboratories Market, 2018 – 2030 (USD Million)
4.5.2 Reference Laboratories Market, Instruments, 2018 – 2030 (USD Million)
4.5.3 Reference Laboratories Market, Instruments, 2018 – 2030, Volume (Units)
4.5.4 Reference Laboratories Market, Consumables, 2018 – 2030 (USD Million)
4.5.5 Reference Laboratories Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.6 Accountable Care Organizations
4.7 Hospital Laboratories
4.7.1 Hospital Laboratories Market, 2018 – 2030 (USD Million)
4.7.2 Hospital Laboratories Market, Instruments, 2018 – 2030 (USD Million)
4.7.3 Hospital Laboratories Market, Instruments, 2018 – 2030, Volume (Units)
4.7.4 Hospital Laboratories Market, Consumables, 2018 – 2030 (USD Million)
4.7.5 Hospital Laboratories Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.8 Urgent Care
4.8.1 Urgent Care Market, 2018 – 2030 (USD Million)
4.8.2 Urgent Care Market, Instruments, 2018 – 2030 (USD Million)
4.8.3 Urgent Care Market, Instruments, 2018 – 2030, Volume (Units)
4.8.4 Urgent Care Market, Consumables, 2018 – 2030 (USD Million)
4.8.5 Urgent Care Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.9 Hospital Emergency Departments
4.9.1 Hospital Emergency Departments Market, 2018 – 2030 (USD Million)
4.9.2 Hospital Emergency Departments Market, Instruments, 2018 – 2030 (USD Million)
4.9.3 Hospital Emergency Departments Market, Instruments, 2018 – 2030, Volume (Units)
4.9.4 Hospital Emergency Departments Market, Consumables, 2018 – 2030 (USD Million)
4.9.5 Hospital Emergency Departments Market, Consumables, 2018 – 2030, Volume (Thousand Units)
4.10 Others
4.10.1 Others Market, 2018 – 2030 (USD Million)
4.10.2 Others Market, Instruments, 2018 – 2030 (USD Million)
4.10.3 Others Market, Instruments, 2018 – 2030, Volume (Units)
4.10.4 Others Market, Consumables, 2018 – 2030 (USD Million)
4.10.5 Others Market, Consumables, 2018 – 2030, Volume (Thousand Units)
Chapter 5 Urinary Tract Infection Market: Segment Analysis, by Type Scope, 2018 – 2030 (USD Million)
5.1 Urinary Tract Infection Market: Type Scope Movement Analysis
5.2 Urethritis
5.2.1 Urethritis Market, 2018 – 2030 (USD Million)
5.3 Cystitis
5.3.1 Cystitis market, 2018 – 2030 (USD Million)
5.4 Pyelonephritis
5.4.1 Pyelonephritis Market, 2018 – 2030 (USD Million)
Chapter 6 Urinary Tract Infection Market: Segment Analysis, By Region, 2018 – 2030 (USD Million)
6.1. Bloodstream Infection Testing Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. North America Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.2.2. U.S.
6.2.3.1. Key Country Dynamics
6.2.2.2. Target Disease Prevalence
6.2.2.3. Competitive Scenario
6.2.2.4. Regulatory Framework
6.2.2.5. Reimbursement Scenario
6.2.2.6. U.S. Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. Reimbursement Scenario
6.2.3.6. Canada Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Europe Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Target Disease Prevalence
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.2.5. Reimbursement Scenario
6.3.2.6. UK Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Reimbursement Scenario
6.3.3.6. Germany Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Reimbursement Scenario
6.3.4.6. France Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. Reimbursement Scenario
6.3.5.6. Italy Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Reimbursement Scenario
6.3.6.6. Spain Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Reimbursement Scenario
6.3.7.6. Denmark Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Reimbursement Scenario
6.3.8.6. Sweden Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Reimbursement Scenario
6.3.9.6. Norway Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.2.5. Reimbursement Scenario
6.4.2.6. Japan Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Reimbursement Scenario
6.4.3.6. China Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. Reimbursement Scenario
6.4.4.6. India Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. Reimbursement Scenario
6.4.5.6. Australia Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Reimbursement Scenario
6.4.6.6. Thailand Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. South Korea Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.2.5. Reimbursement Scenario
6.5.2.6. Brazil Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Reimbursement Scenario
6.5.3.6. Mexico Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Reimbursement Scenario
6.5.4.6. Argentina Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.6. MEA
6.6.1. MEA Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.2.5. Reimbursement Scenario
6.6.2.6. South Africa Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. Reimbursement Scenario
6.6.3.6. Saudi Arabia Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Reimbursement Scenario
6.6.4.6. UAE Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. Reimbursement Scenario
6.6.5.6. Kuwait Bloodstream Infection Testing Market, 2018 – 2030 (USD Million
Chapter 7 Urinary Tract Infection Market: Competitive Analysis
7.1 Key Company Market Share Analysis, 2022
7.2 Company Profiles
7.2.1 QIAGEN
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Accelerate Diagnostics, Inc.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.3 Bio-Rad Laboratories, Inc.
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.4 F. Hoffmann-La Roche Ltd.
7.2.4.1 Company overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Danaher Corporation
7.2.5.1 Company overview
7.2.5.2 Beckman Coulter
7.2.5.3 Financial Performance
7.2.5.4 Product benchmarking
7.2.5.5 Strategic initiatives
7.2.6 Siemens Healthcare GmbH
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Randox Laboratories Ltd.
7.2.7.1 Company overview
7.2.7.2 Product benchmarking
7.2.8 Thermo Fisher Scientific, Inc.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
7.2.9 bioMérieux SA
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 T2 Biosystems, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global urinary tract infection testing market estimates and forecasts, by region, 2018 - 2030 (USD Million) (Instruments and Consumables, Volume, Units)
Table 4 Global urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 5 Global urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 6 Global urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 7 Global urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 8 North America urinary tract infection testing market estimates and forecasts, by country, 2018 - 2030 (USD Million) (Instruments and Consumables, Volume, Units)
Table 9 North America urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 10 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 11 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 12 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 13 U.S. urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 14 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 16 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 17 Canada urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 18 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 20 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 21 Europe urinary tract infection testing market estimates and forecasts, by country, 2018 - 2030 (USD Million) (Instruments and Consumables, Volume, Units)
Table 22 Europe urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 23 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 25 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 26 UK urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 27 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 28 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 29 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 30 Germany urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 31 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 32 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 33 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 34 France urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 35 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 36 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 37 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 38 Italy urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 39 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 40 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 41 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 42 Spain urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 43 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 44 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 45 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 46 Denmark urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 47 Denmark urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 48 Denmark urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 49 Denmark urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 50 Sweden urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 51 Sweden urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 52 Sweden urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 53 Sweden urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 54 Norway urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 55 Norway urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 56 Norway urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 57 Norway urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 58 Asia Pacific urinary tract infection testing market estimates and forecasts, by country, 2018 - 2030 (USD Million) (Instruments and Consumables,Volume, Units)
Table 59 Asia Pacific urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 62 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 63 Japan urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 64 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 65 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 66 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 67 China urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 68 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 69 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 70 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 71 India urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 72 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 74 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 75 Australia urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 76 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 77 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 78 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 79 South Korea urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 80 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 81 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 82 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 83 Thailand urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 84 Thailand urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 Thailand urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 86 Thailand urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 87 Latin America urinary tract infection testing market estimates and forecasts, by country, 2018 - 2030 (USD Million) (Instruments and Consumables, Volume, Units)
Table 88 Latin America urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 89 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 90 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 91 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 92 Brazil urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 93 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 94 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 95 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 96 Mexico urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 97 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 98 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 99 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 100 Argentina urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 101 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 102 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 103 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 104 MEA urinary tract infection testing market estimates and forecasts, by country, 2018 - 2030 (USD Million) (Instruments and Consumables, Volume, Units)
Table 105 MEA urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 106 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 107 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 108 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 109 South Africa urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 110 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 111 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 112 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 113 Saudi Arabia urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 116 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 117 UAE urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 118 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD) Million
Table 119 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 120 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 121 Kuwait urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 122 Kuwait urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD) Million
Table 123 Kuwait urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
Table 124 Kuwait urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 125 List of key distributors

※본 조사보고서 [글로벌 요로 감염증 검사 시장 (2023-2030) : 요도염, 방광염, 신우신염] (코드 : GRV23NOV185) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 요로 감염증 검사 시장 (2023-2030) : 요도염, 방광염, 신우신염] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 펩티드 마이크로어레이 시장 (2023~2030) : 질환 진단, 단백질 기능 분석
GRV23MA024 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 펩티드 마이크로어레이 시장 규모가 2023년부터 2030년 사이에 연평균 4.51% 성장하여, 2030년에는 1,133.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 펩티드 마이크로어레이 시장을...Peptide Microarray Market Growth & Trends The global peptide microarray market size is expected to reach USD 1,133.5 million by 2030, registering a CAGR of 4.51% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate...

세계의 라벨 프리 어레이 시스템 시장 (2023~2030) : 표면 플라즈몬 공명, 생체층 간섭, 세포 유전 분광
GRV23MR110 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 라벨 프리 어레이 시스템 시장 규모가 2023년부터 2030년 사이에 CAGR 7.42% 증가하여, 2030년에는 799.59백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는...Label-free Array System Market Growth & Trends The global label-free array system market size is expected to reach USD 799.59 million by 2030, expanding at a CAGR of 7.42% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial...

세계의 맞춤형 항체 시장 (2023~2030) : 단클론 항체, 폴리클로날 항체, 재조합 항체, 기타
GRV23MR076 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 맞춤형 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 301.7백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는 세계의 맞춤형...Custom Antibody Market Growth & Trends The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during...

세계의 미생물 API 시장 2023-2030 : 호스별 (포유류, 박테리아, 곰팡이), 유형별 (항체, 펩타이드, 단백질), 부위별, 분자별, 최종 용도별, 지역별
GRV24JAN164 / Grand View Research / 2023년 11월 / 글로벌 미생물 API 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 미생물 API 시장 규모는 2030년까지 961억1000만 달러에 달할 것으로 예상되며, 2023년에서 2030년까지 6.66%의 CAGR을 기록할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 미생물 API 시장 변수/동향/범위 4. 세계의 미생물 API 시장 규모 : 호스트별 비즈니스 분석 5. 세계의 미생물 API 시장 규모 : 유형별 비즈니스 분석 6. 세계의 미생물 API 시장 규모 : 사이트별 비즈니스 분석 7. 세계의 미생물 API 시장 규모 :...

글로벌 항바이러스제 시장 (2023-2030) : 브랜드, 제네릭
GRV23NOV002 / Grand View Research / 2023년 9월 / 글로벌 항바이러스제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 항바이러스제 시장 규모는 2023년부터 2030년까지 연평균 성장률 -1. 99%를 기록하며 2030년까지 620. 5억 달러에 달할 것으로 예상됩니다. 이러한...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 항바이러스제 시장 : 유형별 분석 Chapter 5. 세계의 항바이러스제 시장 : 약품 종류별 분석 Chapter 6. 세계의 항바이러스제 시장 : 유통 채널별 분석 Chapter 7. 세계의 항바이러스제 시장 : 용도별 분석 Chapter 8. 세계의...